Literature DB >> 1363010

Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus.

B A Rideout1, P F Moore, N C Pedersen.   

Abstract

A significant elevation in the percentage of CD4+ and CD8+ T-lymphocytes expressing major histocompatibility complex (MHC) Class II antigens was observed in the blood of cats shortly after they were experimentally infected with feline immunodeficiency virus (FIV). In addition to an increase in the relative proportion of T-lymphocytes expressing Class II antigens, there was an increase in the density of Class II antigens on the cell surface. These elevations were still evident at the completion of the 5 month study. A second group of cats that had been infected with FIV for almost 5 years, and with either normal or abnormally low levels of CD4+ T-lymphocytes, had similar elevations in MHC II expression, suggesting that such abnormalities are lifelong. Cats with chronic (2 year) feline leukemia virus (FeLV) infection or dual FIV/FeLV infections also showed similar alterations in MHC II expression on CD4+ and CD8+ T-lymphocytes, suggesting that these alterations were not FIV specific. Feline T-lymphocytes expressed more MHC II antigen and interleukin-2 (IL-2) receptor following stimulation in vitro with conconavalin A and IL-2, demonstrating that feline T-lymphocytes respond to activation signals in a manner similar to T-lymphocytes of other species. However, changes in MHC II expression on T-cells of FIV infected cats were not explainable by viral induced T-cell activation alone, because FIV infected cats with elevated MHC II expression did not have coincident elevations in IL-2 receptor expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1363010     DOI: 10.1016/0165-2427(92)90122-7

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  10 in total

1.  Bovine lentivirus induces early transient B-cell proliferation in experimentally inoculated cattle and appears to be pantropic.

Authors:  C A Whetstone; D L Suarez; J M Miller; B A Pesch; J A Harp
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 2.  Vaccination of Immunocompromised Cats.

Authors:  Katrin Hartmann; Karin Möstl; Albert Lloret; Etienne Thiry; Diane D Addie; Sándor Belák; Corine Boucraut-Baralon; Herman Egberink; Tadeusz Frymus; Regina Hofmann-Lehmann; Hans Lutz; Fulvio Marsilio; Maria Grazia Pennisi; Séverine Tasker; Uwe Truyen; Margaret J Hosie
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

Review 3.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

4.  The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression.

Authors:  E Holznagel; R Hofmann-Lehmann; C M Leutenegger; K Allenspach; S Huettner; U Forster; E Niederer; H Joller; B J Willett; U Hummel; G L Rossi; J Schüpbach; H Lutz
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 5.  Clinical aspects of feline immunodeficiency and feline leukemia virus infection.

Authors:  Katrin Hartmann
Journal:  Vet Immunol Immunopathol       Date:  2011-07-21       Impact factor: 2.046

Review 6.  FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review.

Authors:  E W Uhl; T G Heaton-Jones; R Pu; J K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2002-12       Impact factor: 2.046

Review 7.  Bovine Foamy Virus: Shared and Unique Molecular Features In Vitro and In Vivo.

Authors:  Magdalena Materniak-Kornas; Juan Tan; Anke Heit-Mondrzyk; Agnes Hotz-Wagenblatt; Martin Löchelt
Journal:  Viruses       Date:  2019-11-21       Impact factor: 5.048

Review 8.  Clinical aspects of feline retroviruses: a review.

Authors:  Katrin Hartmann
Journal:  Viruses       Date:  2012-10-31       Impact factor: 5.048

9.  Cloning, expression and characterization of biologically active feline tumour necrosis factor-alpha.

Authors:  E Rimstad; G H Reubel; G A Dean; J Higgins; N C Pedersen
Journal:  Vet Immunol Immunopathol       Date:  1995-04       Impact factor: 2.046

10.  FIV infection of IL-2-dependent and -independent feline lymphocyte lines: host cells range distinctions and specific cytokine upregulation.

Authors:  D L Lerner; C K Grant; A de Parseval; J H Elder
Journal:  Vet Immunol Immunopathol       Date:  1998-10-23       Impact factor: 2.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.